Details for: HEMLIBRA
Company: HOFFMANN-LA ROCHE LIMITED
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02479621 | HEMLIBRA | EMICIZUMAB | 30 MG / 1 ML | SOLUTION | SUBCUTANEOUS |
| 02479648 | HEMLIBRA | EMICIZUMAB | 60 MG / 0.4 ML | SOLUTION | SUBCUTANEOUS |
| 02479656 | HEMLIBRA | EMICIZUMAB | 105 MG / 0.7 ML | SOLUTION | SUBCUTANEOUS |
| 02479664 | HEMLIBRA | EMICIZUMAB | 150 MG / ML | SOLUTION | SUBCUTANEOUS |
Summary Reports
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.